The San Diego Business Journal’s Fred Grier recently highlighted Kay Olmstead and Nano PharmaSolutions, Inc., a San Diego-based company that has developed a drug delivery platform for poorly soluble drugs in preclinical and post-approval stages.
The $149,000 investment in Nano PharmaSolutions represents an innovative collaboration between Realize Impact and Mission Driven Finance.